Shandong Anhong Pharmaceutical is an API manufacturer based in China. It holds 26 active US drug master files and 14 valid CEPs. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 22 February 2019 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Dezhou City, China | Not on file |
| Dezhou, China | Not on file |
| China, China | 3003877289 |
| Molecule | Regulators | Docs |
|---|---|---|
| Gefitinib | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Sorafenib | EDQM, SFDA (Saudi Arabia) | 3 |
| Cefotaxime | EDQM, US FDA | 2 |
| Ertapenem | US FDA | 2 |
| Etoposide | EDQM, US FDA | 2 |
| Exemestane | EDQM, US FDA | 2 |
| Meropenem Trihydrate | EDQM | 2 |
| Palbociclib | SFDA (Saudi Arabia), US FDA | 2 |
| Pemetrexed | SFDA (Saudi Arabia), US FDA | 2 |
| Ropivacaine | EDQM, US FDA | 2 |
| Terbinafine | EDQM, US FDA | 2 |
| Abemaciclib | US FDA | 1 |
| Abiraterone | US FDA | 1 |
| Afatinib | US FDA | 1 |
| Azacitidine | US FDA | 1 |
| Bexarotene | US FDA | 1 |
| Cabazitaxel | US FDA | 1 |
| Cilastatin | US FDA | 1 |
| Cilastatin Sodium | EDQM | 1 |
| Enzalutamide | US FDA | 1 |
| Imipenem | US FDA | 1 |
| Imipenem Monohydrate | EDQM | 1 |
| Lasmiditan | US FDA | 1 |
| Lenalidomide | US FDA | 1 |
| Meropenem | US FDA | 1 |
| Nintedanib | US FDA | 1 |
| Nintedanib Esylate | SFDA (Saudi Arabia) | 1 |
| Olaparib | US FDA | 1 |
| Pemetrexed Disodium | SFDA (Saudi Arabia) | 1 |
| Pemetrexed Disodium 2.5-Hydrate | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| EMA | None | 4 |
Choose your molecules and target markets. Shandong Anhong Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free